Hunan Hansen Pharmaceutical Co Ltd (002412) — Financial Flexibility Index
Hunan Hansen Pharmaceutical Co Ltd (002412) has a Financial Flexibility Index of 0.19x as of September 2025. Free cash flow of CN¥56.32 Million (operating CF CN¥52.51 Million minus capex CN¥3.82 Million) represents 0% of total liabilities (CN¥301.66 Million). Check 002412 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Hunan Hansen Pharmaceutical Co Ltd Financial Flexibility Index (2007–2025)
Historical Financial Flexibility Index trend for Hunan Hansen Pharmaceutical Co Ltd across 19 annual periods. See how liquid is Hunan Hansen Pharmaceutical Co Ltd's working capital to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Hunan Hansen Pharmaceutical Co Ltd (2007–2025)
Year-by-year free cash flow to debt coverage for Hunan Hansen Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 002412 company net worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.82x | CN¥256.48 Million | CN¥245.38 Million | CN¥312.15 Million | ▲ +98.4% |
| 2024 | 0.41x | CN¥142.42 Million | CN¥130.78 Million | CN¥343.85 Million | ▼ -14.3% |
| 2023 | 0.48x | CN¥180.42 Million | CN¥160.95 Million | CN¥373.46 Million | ▲ +23.4% |
| 2022 | 0.39x | CN¥155.31 Million | CN¥143.81 Million | CN¥396.81 Million | ▼ -67.3% |
| 2021 | 1.20x | CN¥441.87 Million | CN¥212.54 Million | CN¥368.99 Million | ▲ +20.8% |
| 2020 | 0.99x | CN¥291.27 Million | CN¥162.19 Million | CN¥293.92 Million | ▲ +74.2% |
| 2019 | 0.57x | CN¥200.82 Million | CN¥165.11 Million | CN¥352.93 Million | ▼ -12.2% |
| 2018 | 0.65x | CN¥282.05 Million | CN¥217.52 Million | CN¥435.02 Million | ▲ +98.2% |
| 2017 | 0.33x | CN¥157.38 Million | CN¥107.18 Million | CN¥481.18 Million | ▼ -34.0% |
| 2016 | 0.50x | CN¥206.07 Million | CN¥161.16 Million | CN¥415.88 Million | ▼ -54.9% |
| 2015 | 1.10x | CN¥139.46 Million | CN¥63.57 Million | CN¥126.83 Million | ▲ +48.6% |
| 2014 | 0.74x | CN¥158.80 Million | CN¥85.05 Million | CN¥214.59 Million | ▼ -14.0% |
| 2013 | 0.86x | CN¥184.53 Million | CN¥76.09 Million | CN¥214.46 Million | ▼ -70.0% |
| 2012 | 2.87x | CN¥220.10 Million | CN¥100.23 Million | CN¥76.76 Million | ▲ +71.7% |
| 2011 | 1.67x | CN¥91.74 Million | CN¥53.84 Million | CN¥54.95 Million | ▲ +231.3% |
| 2010 | 0.50x | CN¥24.81 Million | CN¥21.24 Million | CN¥49.23 Million | ▼ -44.6% |
| 2009 | 0.91x | CN¥61.56 Million | CN¥41.02 Million | CN¥67.69 Million | ▲ +63.9% |
| 2008 | 0.55x | CN¥46.98 Million | CN¥33.94 Million | CN¥84.67 Million | ▼ -12.6% |
| 2007 | 0.64x | CN¥54.93 Million | CN¥37.75 Million | CN¥86.49 Million | — |